Exclusive

Publication

Byline

Location

International Patent: COMPOSITIONS AND METHODS FOR TREATING ALZHEIMER'S DISEASE IN PRIMATES

GENEVA, June 24 -- NEUEXCELL THERAPEUTICS (SUZHOU) CO., LTD. filed a patent application (CN2025/137806) for “COMPOSITIONS AND METHODS FOR TREATING ALZHEIMER'S DISEASE IN PRIMATES”. With publication no... Read More


International Patent: LCOS DEVICE FOR OPTICAL COMMUNICATION

GENEVA, June 24 -- THE HONG KONG UNIVERSITY OF SCIENCE AND TECHNOLOGY filed a patent application (CN2025/137763) for “LCOS DEVICE FOR OPTICAL COMMUNICATION”. With publication no. WO/2026/114260, here ... Read More


International Patent: METHOD FOR SEQUENCING GLYCAN

GENEVA, June 24 -- SHANGHAI INSTITUTE OF MATERIA MEDICA. CHINESE ACADEMY OF SCIENCES filed a patent application (CN2025/137765) for “METHOD FOR SEQUENCING GLYCAN”. With publication no. WO/2026/114261,... Read More


International Patent: APPLICATION PROCESSING METHOD AND RELATED APPARATUS

GENEVA, June 24 -- HUAWEI TECHNOLOGIES CO., LTD. filed a patent application (CN2025/137767) for “APPLICATION PROCESSING METHOD AND RELATED APPARATUS”. With publication no. WO/2026/114262, here are the... Read More


International Patent: LIQUID BIS(FLUOROSULFONYL)IMIDE METAL SALT AND PREPARATION METHOD THEREFOR

GENEVA, June 24 -- JIUJIANG TINCI MATERIALS TECHNOLOGY CO., LTD. filed a patent application (CN2025/137780) for “LIQUID BIS(FLUOROSULFONYL)IMIDE METAL SALT AND PREPARATION METHOD THEREFOR”. With publi... Read More


International Patent: FUSION PROTEIN AND USE THEREOF

GENEVA, June 24 -- SHANGHAI INNOGEN PHARMACEUTICAL TECHNOLOGY CO., LTD. filed a patent application (CN2025/137747) for “FUSION PROTEIN AND USE THEREOF”. With publication no. WO/2026/114257, here are t... Read More


International Patent: BCL-2/BCL-XL PROTEIN DEGRADER AND USE THEREOF

GENEVA, June 24 -- ASCENTAGE PHARMA (SUZHOU) CO., LTD. filed a patent application (CN2025/137750) for “BCL-2/BCL-XL PROTEIN DEGRADER AND USE THEREOF”. With publication no. WO/2026/114258, here are the... Read More


International Patent: USE OF FACTOR B INHIBITOR IN TREATMENT OF PAROXYSMAL NOCTURNAL HEMOGLOBINURIA

GENEVA, June 24 -- JIANGSU HENGRUI PHARMACEUTICALS CO., LTD. filed a patent application (CN2025/137757) for “USE OF FACTOR B INHIBITOR IN TREATMENT OF PAROXYSMAL NOCTURNAL HEMOGLOBINURIA”. With public... Read More


International Patent: COMMUNICATION METHOD, AND COMMUNICATION APPARATUS AND SYSTEM

GENEVA, June 24 -- HUAWEI TECHNOLOGIES CO., LTD. filed a patent application (CN2025/137732) for “COMMUNICATION METHOD, AND COMMUNICATION APPARATUS AND SYSTEM”. With publication no. WO/2026/114254, her... Read More


International Patent: COMMUNICATION METHOD AND APPARATUS AND SYSTEM

GENEVA, June 24 -- HUAWEI TECHNOLOGIES CO., LTD. filed a patent application (CN2025/137743) for “COMMUNICATION METHOD AND APPARATUS AND SYSTEM”. With publication no. WO/2026/114255, here are the other... Read More